Structured around a primary injury recovery period followed by a maintenance and resilience phase. BPC-157 and TB-500 form the recovery foundation; Collagen and GHK-Cu maintain year-round.
The injury recovery protocol is divided into two phases. Phase 1 (months 1–5) is the acute recovery phase — Arg-BPC-157 daily and TB-500 at loading dose twice weekly, with MGF added from month 2 for muscle and tendon tear recovery. Phase 2 (months 6+) is the resilience and maintenance phase — lower frequency dosing with Collagen and GHK-Cu as the continuous backbone.
The specific phasing is designed to match the biology of connective tissue healing: BPC-157 and TB-500 are most critical in the inflammatory and proliferative phases (weeks 1–12). Collagen becomes the dominant factor during remodelling (months 3–6+).
This protocol uses Arg-BPC-157 — the arginine salt form — rather than the standard acetate salt. The arginine form has greater stability, improved bioavailability, and is generally considered superior for systemic administration. For gut issues, oral BPC-157 (standard or Arg form) at 500mcg–1mg achieves high local concentration without injection.
Four panels for a full recovery year: January baseline (hsCRP, full blood count, metabolic), April (progress: hsCRP, pain scores, range of motion), August (recovery assessment: hsCRP, imaging if available), December (annual: full panel, injury recurrence review). hsCRP is the key inflammatory marker for tracking healing progress.
Full dosing, titration schedule, blood work timing and cycling notes are available inside the platform. Use the calendar to track your protocol.